Idiopathic Pulmonary Fibrosis (IPF)
Part of Respiratory diseases
Companies in Idiopathic Pulmonary Fibrosis (IPF)

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
BenevolentAI
London, UK
BenevolentAI, founded in 2013 and headquartered in London, United Kingdom, is a drug discovery company that was delisted from Euronext Amsterdam and merged with Osaka Holdings S...
...more
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
DJS Antibodies
Oxford, United Kingdom
DJS Antibodies was a UK-based biotechnology company specializing in the discovery and development of novel antibody therapeutics for chronic inflammatory conditions. The company...
...more
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
AstraZeneca
Cambridge, UK
AstraZeneca is a pharmaceutical company engaged in multi-year AI-powered drug discovery collaborations to identify validated targets in various disease areas.
...morePliant Therapeutics
South San Francisco, CA, United States
Pliant Therapeutics is a company developing treatments for fibrotic diseases.
